The Efficacy and Safety of Homoharringtonine Added to Venetoclax and Azacitidine in the Frontline Treatment of Newly Diagnosed Acute Myeloid Leukemia, a Multi-Center Exploratory Cohort Study

被引：0
作者：
Yu, Guopan [1 ]
Yao, Zurong [1 ]
Yin, Zhao [1 ]
Zhang, Yu [1 ]
Zhao, Weihua [2 ]
Weng, Guangyang [3 ]
Guo, Ziwen [4 ]
Sun, Zhiqiang [5 ]
Shi, Pengcheng [1 ]
Jiang, Xuejie [6 ]
Xu, Dan [1 ]
Xuan, Li [1 ]
Liu, Qifa [1 ]
机构：
[1] Southern Med Univ, Nanfang Hosp, Dept Hematol, Guangzhou, Peoples R China
[2] Guangxi Med Univ, Affiliated Hosp 1, Dept Hematol, Nanning, Peoples R China
[3] Shenzhen Second Peoples Hosp, Dept Hematol, Shenzhen, Peoples R China
[4] Zhongshan City Peoples Hosp, Dept Hematol, Zhongshan, Peoples R China
[5] Southern Med Univ, Shenzhen Hosp, Dept Hematol, Shenzhen, Peoples R China
[6] Guangzhou Med Univ, Affiliated Hosp 2, Dept Hematol, Guangzhou, Peoples R China
来源：
BLOOD | 2024年 / 144卷
关键词：
homoharringtonine; venetoclax/azacitidine; acute myeloid leukemia; efficacy; safety;
D O I：
10.1182/blood-2024-206872
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：4283 / 4283
页数：1
相关论文
共 50 条
  • [31] Efficacy and safety of cladribine addition to induction treatment of newly diagnosed acute myeloid leukemia: a systematic review and meta-analysis
    Pan, Qianying
    Li, Juan
    HEMATOLOGY, 2021, 26 (01) : 577 - 587
  • [32] Low dose venetoclax plus itraconazole outpatient induction in newly diagnosed acute myeloid leukemia: A phase 2 study
    De la Garza-Salazar, Fernando
    Colunga-Pedraza, Perla Rocio
    Gomez-Almaguer, David
    Garcia-Zarate, Valeria Abigail
    Gomez-De Leon, Andres
    LEUKEMIA RESEARCH, 2023, 133
  • [33] Sorafenib plus triplet therapy with venetoclax, azacitidine and homoharringtonine for refractory/relapsed acute myeloid leukemia with FLT3-ITD: A multicenter phase 2 study
    Yu, Sijian
    Zhang, Yu
    Yu, Guopan
    Wang, Yu
    Shao, Ruoyang
    Du, Xin
    Xu, Na
    Lin, Dongjun
    Zhao, Weihua
    Zhang, Xiong
    Xiao, Jie
    Sun, Zhiqiang
    Deng, Lan
    Liang, Xinquan
    Zhang, Hongyu
    Guo, Ziwen
    Dai, Min
    Shi, Pengcheng
    Huang, Fen
    Fan, Zhiping
    Liu, Qiong
    Lin, Ren
    Jiang, Xuejie
    Xuan, Li
    Liu, Qifa
    Jin, Hua
    JOURNAL OF INTERNAL MEDICINE, 2024, 295 (02) : 216 - 228
  • [34] A phase Ⅳ study of homoharringtonine, cytarabine, aclacinomycin and G-CSF(HCAG) regimen compared with traditional IA regimen in the treatment of newly diagnosed elderly acute myeloid leukemia patients
    刘钊
    张赟翔
    王丽宁
    XIA Zheng
    MAO Yuan-fei
    ZHAO Hui-jin
    YOU Jian-hua
    YU Yang
    ZHAO Yu-bing
    REN Yu-hong
    LI Ya
    WANG Yan
    CHEN Qiu-sheng
    李军民
    陈瑜
    上海交通大学学报(医学版), 2017, 37 (08) : 1100 - 1105
  • [35] Expression of integrin alpha7 in newly diagnosed acute myeloid leukemia patients: a cohort study
    Elaggan, Hanaa
    Bedewy, Ahmed M.
    Abd Elrahman, Ahmed
    Hassanein, Aya M.
    Nawar, Sarah M.
    EGYPTIAN JOURNAL OF HAEMATOLOGY, 2024, 49 (03) : 295 - 299
  • [36] First Results of a Phase II Study (STIMULUS-AML1) Investigating Sabatolimab plus Azacitidine plus Venetoclax in Patients With Newly Diagnosed Acute Myeloid Leukemia (ND AML)
    Zeidan, Amer M.
    Westermann, Joerg
    Kovacsovics, Tibor
    Assouline, Sarit
    Schuh, Andre C.
    Kim, Hee-Je
    Macias, Gabriela Rodriguez
    Sanford, David
    Luskin, Marlise R.
    Stein, Eytan M.
    Malek, Kamel
    Lyu, Jiaying
    Stegert, Mario
    Esteve, Jordi
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S255 - S255
  • [37] The safety profile of FLT3 inhibitors in the treatment of newly diagnosed or relapsed/refractory acute myeloid leukemia
    Marconi, Giovanni
    Giannini, Maria Benedetta
    Bagnato, Gianmarco
    Simonetti, Giorgia
    Cerchione, Claudio
    Mosquera Orgueira, Adrian
    Musuraca, Gerardo
    Martinelli, Giovanni
    EXPERT OPINION ON DRUG SAFETY, 2021, 20 (07) : 791 - 799
  • [38] Real-World Experience with Venetoclax Treatment for Newly-Diagnosed Acute Myeloid Leukemia in Japan (VENUS Study): An Interim Analysis Focusing on Neutropenia Management
    Goto, Tatsunori
    Numata, Hiroki
    Katsuoka, Yuna
    Uoshima, Nobuhiko
    Hara, Satoru
    Ando, Jun
    Ota, Shuichi
    Yoshimoto, Goichi
    Matsuoka, Akihito
    Hashiba, Hideyuki
    Morita, Tetsuo
    Tsutsui, Atsuko
    Imanaka, Ryota
    ONCOLOGY AND THERAPY, 2025, : 519 - 527
  • [39] Risk-stratified treatment of sonrotoclax with chemotherapy in newly diagnosed acute myeloid leukemia: a study protocol
    Zhang, Yunxiang
    Wu, Min
    Jin, Zhen
    Yang, Li
    Huang, Xufei
    Li, Weiming
    Zhu, Hongming
    Wang, Wenfang
    Chen, Qiusheng
    Liu, Ligen
    Chen, Zhichao
    Wang, Shaoyuan
    Li, Junmin
    FUTURE ONCOLOGY, 2025, 21 (08) : 953 - 958
  • [40] No association of benzoyl peroxide use with acute myeloid leukemia and hematologic malignancies in a multi-center retrospective study
    Chan, Ryan
    Roster, Katie
    Neubauer, Zachary
    Hill, Rachel C.
    Lipner, Shari R.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2024, 91 (06) : 1234 - 1236
12345